Study Stopped
Sponsor no longer performing clinical studies. Will only be a manufacturer
AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)
1 other identifier
observational
513
1 country
25
Brief Summary
AcQMap Registry is an observation study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Typical duration for all trials
25 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2020
CompletedFirst Posted
Study publicly available on registry
June 16, 2020
CompletedStudy Start
First participant enrolled
September 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 8, 2023
CompletedNovember 13, 2023
November 1, 2023
3.1 years
June 11, 2020
November 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Procedural Ablation Outcomes
Number of participants who had termination of ablated arrhythmia's to Sinus Rhythm or another arrhythmia within 12 hours post ablation procedure with or without electrical or pharmacological cardioversion
12 hours
Secondary Outcomes (1)
Long-term Outcome
3 years
Interventions
To evaluate procedural and long-term outcomes when using the diagnostic AcQMap System as an imaging and mapping system for ablation of arrhythmias in accordance with the Instructions for Use (IFU).
Eligibility Criteria
Any participant 18 years of age or older. Currently scheduled for an ablation of an arrhythmia utilizing the diagnostic AcQMap System.
You may qualify if:
- Male or female 18 years of age or older. Currently scheduled for an ablation of an arrhythmia utilizing the diagnostic AcQMap System.
- Willingness, ability and commitment to participate in baseline and follow-up evaluations for the full length of the study.
- Willing and able to give written informed consent.
You may not qualify if:
- In the opinion of the Investigator, any known contraindications to an ablation procedure.
- Current enrollment in any study protocol sponsored by Acutus Medical. Any other condition that, in the judgment of the investigator, makes the participant a poor candidate for this procedure, the study, or compliance with the protocol (includes vulnerable patient population, mental illness, addictive disease, extensive travel away from the research center, etc.).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Acutus Medicallead
Study Sites (25)
Grandview Medical Group Research
Birmingham, Alabama, 35243, United States
Banner University Medical Institute
Phoenix, Arizona, 85006, United States
St Jude Medical Center
Fullerton, California, 92835, United States
University California San Diego
La Jolla, California, 92037, United States
Keck School of Medicine of USC
Los Angeles, California, 90033, United States
Mission Heritage Mission Viejo - Cardiac Electrophysiology
Mission Viejo, California, 92691, United States
Eisenhower Medical Center
Rancho Mirage, California, 92270, United States
Dignity Health Research Institute
Sacramento, California, 95819, United States
Bethesda Hospital East
Boynton Beach, Florida, 33435, United States
Clearwater Cardiovascular Consultants
Clearwater, Florida, 33756, United States
Ascension St. Vincent's Medical Center Riverside
Jacksonville, Florida, 32204, United States
Celebration Hospital
Orlando, Florida, 32803, United States
Sarasota Memorial Research Institute
Sarasota, Florida, 34239, United States
Bayfront (Orlando Health)
St. Petersburg, Florida, 33701, United States
Saint Alphonsus Health System
Boise, Idaho, 83704, United States
Kansas City Heart Rhythm Institute
Overland Park, Kansas, 66211, United States
Baptist Lexington Medical Center
Lexington, Kentucky, 40503, United States
Henry Ford Health Center
Detroit, Michigan, 48202, United States
Nevada Heart and Vascular
Las Vegas, Nevada, 89118, United States
Morristown Medical Center
Morristown, New Jersey, 07960, United States
Weill Cornell Medicine, New York Presbyterian Hospital
New York, New York, 10021, United States
ProMedica Physician Cardiology
Toledo, Ohio, 43606, United States
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033-0850, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, 78750, United States
Methodist Healthcare
San Antonio, Texas, 78249, United States
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2020
First Posted
June 16, 2020
Study Start
September 29, 2020
Primary Completion
November 8, 2023
Study Completion
November 8, 2023
Last Updated
November 13, 2023
Record last verified: 2023-11